Differences in the characteristics of tolerance to μ-opioid receptor agonists in the colon from wild type and β-arrestin2 knockout mice

European Journal of Pharmacology

Volumn 685, Issue 1-3, 2012, Pages 133-140

  Maguma, Hercules T ^a   Dewey, William L ^a   Akbarali, Hamid I ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

Author keywords

Circular smooth muscle; Opioid; Tolerance; Arrestin2; Opioid receptor

Indexed keywords

BETA ARRESTIN 2; ENKEPHALIN[2 DEXTRO ALANINE 4 METHYLPHENYLALANINE 5 GLYCINE]; ETORPHINE; FENTANYL; MU OPIATE RECEPTOR; MU OPIATE RECEPTOR AGONIST;

ANIMAL TISSUE; ARTICLE; COLON; CONTROLLED STUDY; DOWN REGULATION; DRUG EXPOSURE; DRUG TOLERANCE; DRUG USE; FUNCTIONAL ASSESSMENT; ILEUM; IN VITRO STUDY; INTESTINE EXAMINATION; KNOCKOUT MOUSE; LONG TERM EXPOSURE; MOLECULAR DYNAMICS; MOUSE; MUSCLE CONTRACTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN LOCALIZATION; SENSITIVITY ANALYSIS; WILD TYPE;

EID: 84861347667     PISSN: 00142999     EISSN: 18790712     Source Type: Journal    
DOI: 10.1016/j.ejphar.2012.04.001     Document Type: Article

References (31)

1. Akbarali, H., Bieger, D., Triggle, C.R., 1987. Effects of cold storage on relaxation responses in the rat oesophageal tunica muscularis mucosae. Can. J. Physiol. Pharmacol. 65, 23-29.
2. Bailey, C.P., Connor, M., 2005. Opioids: cellular mechanisms of tolerance and physical dependence. Curr. Opin. Pharmacol. 5, 60-68.
3. Bernstein, M.A., Welch, S.P., 1998. mu-Opioid receptor down-regulation and cAMPdependent protein kinase phosphorylation in a mouse model of chronic morphine tolerance. Brain Res. Mol. Brain Res. 55, 237-242.
4. Bloom, A.S., Dewey, W.L., 1978. A comparison of some pharmacological actions of morphine and delta9-tetrahydrocannabinol in the mouse. Psychopharmacology (Berl) 57, 243-248.
5. Bohn, L.M., Gainetdinov, R.R., Lin, F.T., Lefkowitz, R.J., Caron, M.G., 2000. Mu-opioid receptor desensitization by beta-arrestin-2 determines morphine tolerance but not dependence. Nature 408, 720-723.
6. Bohn, L.M., Lefkowitz, R.J., Caron, M.G., 2002. Differential mechanisms of morphine antinociceptive tolerance revealed in (beta)arrestin-2 knock-out mice. J. Neurosci. 22, 10494-10500.
7. Gray, A.C., White, P.J., Coupar, I.M., 2005. Characterisation of opioid receptors involved in modulating circular and longitudinal muscle contraction in the rat ileum. Br. J. Pharmacol. 144, 687-694.
8. Grider, J.R., Makhlouf, G.M., 1987. Suppression of inhibitory neural input to colonic circular muscle by opioid peptides. J. Pharmacol. Exp. Ther. 243, 205-210.
9. Hine, B., 1985. Morphine and delta 9-tetrahydrocannabinol: two-way cross tolerance for antinociceptive and heart-rate responses in the rat. Psychopharmacology (Berl) 87, 34-38.
10. Holzer, P., 2009. Opioid receptors in the gastrointestinal tract. Regul. Pept. 155, 11-17.
11. Holzer, P., Ahmedzai, S.H., Niederle, N., Leyendecker, P., Hopp, M., Bosse, B., Spohr, I., Reimer, K., 2009. Opioid-induced bowel dysfunction in cancer-related pain: causes, consequences, and a novel approach for its management. J. Opioid Manag. 5, 145-151.
12. Hull, L.C., Llorente, J., Gabra, B.H., Smith, F.L., Kelly, E., Bailey, C., Henderson, G., Dewey, W.L., 2010. The effect of protein kinase C and G protein-coupled receptor kinase inhibition on tolerance induced by mu-opioid agonists of different efficacy. J. Pharmacol. Exp. Ther. 332, 1127-1135.
13. Iwata, H., Tsuchiya, S., Nakamura, T., Yano, S., 2007. Morphine leads to contraction of the ileal circular muscle via inhibition of the nitrergic pathway in mice. Eur. J. Pharmacol. 574, 66-70.
14. Johnson, E.A., Oldfield, S., Braksator, E., Gonzalez-Cuello, A., Couch, D., Hall, K.J., Mundell, S.J., Bailey, C.P., Kelly, E., Henderson, G., 2006. Agonist-selective mechanisms of mu-opioid receptor desensitization in human embryonic kidney 293 cells. Mol. Pharmacol. 70, 676-685.
15. Kang, M., Maguma, H.T., Smith, T.H., Ross, G.R., Dewey, W.L., Akbarali, H.I., 2012. The role of beta-arrestin2 in the mechanism of morphine tolerance in the mouse and guinea pig gastrointestinal tract. J. Pharmacol. Exp. Ther. 340, 567-576.
16. Koch, T., Schulz, S., Schroder, H., Wolf, R., Raulf, E., Hollt, V., 1998. Carboxyl-terminal splicing of the rat mu opioid receptor modulates agonist-mediated internalization and receptor resensitization. J. Biol. Chem. 273, 13652-13657.
17. McPherson, J., Rivero, G., Baptist, M., Llorente, J., Al-Sabah, S., Krasel, C., Dewey, W.L., Bailey, C.P., Rosethorne, E.M., Charlton, S.J., Henderson, G., Kelly, E., 2010.mu-Opioid receptors: correlation of agonist efficacy for signallingwith ability to activate internalization. Mol. Pharmacol. 78, 756-766.
18. Narita, M., Mizoguchi, H., Kampine, J.P., Tseng, L.F., 1996. Role of protein kinase C in desensitization of spinal delta-opioid-mediated antinociception in the mouse. Br. J. Pharmacol. 118, 1829-1835.
19. Nobles, K.N., Xiao, K., Ahn, S., Shukla, A.K., Lam, C.M., Rajagopal, S., Strachan, R.T., Huang, T.Y., Bressler, E.A., Hara, M.R., Shenoy, S.K., Gygi, S.P., Lefkowitz, R.J., 2011. Distinct phosphorylation sites on the beta(2)-adrenergic receptor establish a barcode that encodes differential functions of beta-arrestin. Sci. Signal. 4, ra51.
20. Pawar, M., Kumar, P., Sunkaraneni, S., Sirohi, S., Walker, E.A., Yoburn, B.C., 2007. Opioid agonist efficacy predicts the magnitude of tolerance and the regulation of mu-opioid receptors and dynamin-2. Eur. J. Pharmacol. 563, 92-101.
21. Perroy, J., Pontier, S., Charest, P.G., Aubry, M., Bouvier, M., 2004. Real-time monitoring of ubiquitination in living cells by BRET. Nat. Methods 1, 203-208.
22. Raehal, K.M., Schmid, C.L., Groer, C.E., Bohn, L.M., 2011. Functional selectivity at the mu-opioid receptor: implications for understanding opioid analgesia and tolerance. Pharmacol. Rev. 63, 1001-1019.
23. Ross, G.R., Gabra, B.H., Dewey, W.L., Akbarali, H.I., 2008. Morphine tolerance in the mouse ileum and colon. J. Pharmacol. Exp. Ther. 327, 561-572.
24. Shenoy, S.K., Lefkowitz, R.J., 2003. Trafficking patterns of beta-arrestin and G proteincoupled receptors determined by the kinetics of beta-arrestin deubiquitination. J. Biol. Chem. 278, 14498-14506.
25. Shukla, A.K., Violin, J.D., Whalen, E.J., Gesty-Palmer, D., Shenoy, S.K., Lefkowitz, R.J., 2008. Distinct conformational changes in beta-arrestin report biased agonism at seven-transmembrane receptors. Proc. Natl. Acad. Sci. U. S. A. 105, 9988-9993.
26. Sirohi, S., Dighe, S.V., Walker, E.A., Yoburn, B.C., 2008. The analgesic efficacy of fentanyl: relationship to tolerance and mu-opioid receptor regulation. Pharmacol. Biochem. Behav. 91, 115-120.
27. Smith, F.L., Javed, R.R., Smith, P.A., Dewey, W.L., Gabra, B.H., 2006. PKC and PKA inhibitors reinstate morphine-induced behaviors in morphine tolerant mice. Pharmacol. Res. 54, 474-480.
28. Thomas, J., 2008. Opioid-induced bowel dysfunction. J. Pain Symptom Manage. 35, 103-113.
29. Violin, J.D., Lefkowitz, R.J., 2007. Beta-arrestin-biased ligands at seven-transmembrane receptors. Trends Pharmacol. Sci. 28, 416-422.
30. Whistler, J.L., von Zastrow, M., 1998. Morphine-activated opioid receptors elude desensitization by beta-arrestin. Proc. Natl. Acad. Sci. U. S. A. 95, 9914-9919.
31. Zhang, J., Ferguson, S.S., Barak, L.S., Bodduluri, S.R., Laporte, S.A., Law, P.Y., Caron, M.G., 1998. Role for G protein-coupled receptor kinase in agonist-specific regulation of mu-opioid receptor responsiveness. Proc. Natl. Acad. Sci. U. S. A. 95, 7157-7162.